Genesis Therapeutics’ $200 Million Series B Funding Round

Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments.Genesis Therapeutics announced that it has closed…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here